An emerging player in knee osteoarthritis: The infrapatellar fat pad

Arthritis Research and Therapy

Volumn 15, Issue 6, 2013, Pages

  Ioan Facsinay, Andreea ^a   Kloppenburg, Margreet ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; LIPID;

ADIPOSE TISSUE; DISEASE COURSE; HUMAN; INFLAMMATORY CELL; INFRAPATELLAR FAT PAD; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MESENCHYMAL STEM CELL; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; PATELLA; PATHOLOGY;

ADIPOSE TISSUE; HUMANS; OSTEOARTHRITIS, KNEE; PATELLA;

EID: 84891131116     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4422     Document Type: Review

References (66)

1. Saddik D, McNally EG, Richardson M. MRI of Hoffa's fat pad. Skeletal Radiol 2004, 33:433-444.
2. Smillie IS. Diseases of the Knee Joint 1980, London: Churchill Livingstone.
3. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, Van Osch GJ, Van Offel JF, Verhaar JA, De Clerck LS, Somville J. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage 2010, 18:876-882. 10.1016/j.joca.2010.03.014, 20417297.
4. Hoffa A. Influence of adipose tissue with regard to the pathology of the knee joint. JAMA 1904, 43:795-796.
5. Jacobson JA, Lenchik L, Ruhoy MK, Schweitzer ME, Resnick D. MR imaging of the infrapatellar fat pad of Hoffa. Radiographics 1997, 17:675-691. 10.1148/radiographics.17.3.9153705, 9153705.
6. Dye SF, Vaupel GL, Dye CC. Conscious neurosensory mapping of the internal structures of the human knee without intraarticular anesthesia. Am J Sports Med 1998, 26:773-777.
7. Bennell K, Hodges P, Mellor R, Bexander C, Souvlis T. The nature of anterior knee pain following injection of hypertonic saline into the infrapatellar fat pad. J Orthop Res 2004, 22:116-121. 10.1016/S0736-0266(03)00162-1, 14656669.
8. Schweitzer ME, Falk A, Pathria M, Brahme S, Hodler J, Resnick D. MR imaging of the knee: can changes in the intracapsular fat pads be used as a sign of synovial proliferation in the presence of an effusion?. AJR Am J Roentgenol 1993, 160:823-826. 10.2214/ajr.160.4.8456672, 8456672.
9. Hill CL, Gale DG, Chaisson CE, Skinner K, Kazis L, Gale ME, Felson DT. Knee effusions, popliteal cysts, and synovial thickening: association with knee pain in osteoarthritis. J Rheumatol 2001, 28:1330-1337.
10. Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, Gale D, Grainger A, Conaghan P, Felson DT. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007, 66:1599-1603. 10.1136/ard.2006.067470, 2095318, 17491096.
11. Roemer FW, Zhang Y, Niu J, Lynch JA, Crema MD, Marra MD, Nevitt MC, Felson DT, Hughes LB, El-Khoury GY, Englund M, Guermazi A. Multicenter Osteoarthritis Study Investigators Tibiofemoral joint osteoarthritis: risk factors for MR-depicted fast cartilage loss over a 30-month period in the multicenter osteoarthritis study. Radiology 2009, 252:772-780. 10.1148/radiol.2523082197, 2734891, 19635831, Multicenter Osteoarthritis Study Investigators.
12. Hayashi D, Roemer FW, Dhina Z, Kwoh CK, Hannon MJ, Moore C, Guermazi A. Longitudinal assessment of cyst-like lesions of the knee and their relation to radiographic osteoarthritis and MRI-detected effusion and synovitis in patients with knee pain. Arthritis Res Ther 2010, 12:R172. 10.1186/ar3132, 2990999, 20843319.
13. Ai F, Yu C, Zhang W, Morelli JN, Kacher D, Li X. MR imaging of knee osteoarthritis and correlation of findings with reported patient pain. J Huazhong Univ Sci Technolog Med Sci 2010, 30:248-254. 10.1007/s11596-010-0223-0, 20407883.
14. Zhang Y, Nevitt M, Niu J, Lewis C, Torner J, Guermazi A, Roemer F, McCulloch C, Felson DT. Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum 2011, 63:691-699. 10.1002/art.30148, 3056156, 21360498.
15. Roemer FW, Kwoh CK, Hannon MJ, Green SM, Jakicic JM, Boudreau R, Crema MD, Moore CE, Guermazi A. Risk factors for magnetic resonance imaging-detected patellofemoral and tibiofemoral cartilage loss during a six-month period: the joints on glucosamine study. Arthritis Rheum 2012, 64:1888-1898. 10.1002/art.34353, 22213129.
16. Hunter DJ, Lo GH, Gale D, Grainger AJ, Guermazi A, Conaghan PG. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis 2008, 67:206-211. 10.1136/ard.2006.066183, 17472995.
17. Roemer FW, Guermazi A, Zhang Y, Yang M, Hunter DJ, Crema MD, Bohndorf K. Hoffa's Fat Pad: evaluation on unenhanced MR images as a measure of patellofemoral synovitis in osteoarthritis. AJR Am J Roentgenol 2009, 192:1696-1700. 10.2214/AJR.08.2038, 19457837.
18. Subhawong TK, Eng J, Carrino JA, Chhabra A. Superolateral Hoffa's fat pad edema: association with patellofemoral maltracking and impingement. AJR Am J Roentgenol 2010, 195:1367-1373. 10.2214/AJR.10.4668, 3094907, 21098197.
19. Jibri Z, Martin D, Mansour R, Kamath S. The association of infrapatellar fat pad oedema with patellar maltracking: a case-control study. Skeletal Radiol 2012, 41:925-931. 10.1007/s00256-011-1299-8, 22012480.
20. Loeuille D, Sauliere N, Champigneulle J, Rat AC, Blum A, Chary-Valckenaere I. Comparing non-enhanced and enhanced sequences in the assessment of effusion and synovitis in knee OA: associations with clinical, macroscopic and microscopic features. Osteoarthritis Cartilage 2011, 19:1433-1439. 10.1016/j.joca.2011.08.010, 21930225.
21. de Lange-Brokaar BJE, Ioan-Facsinay A, Yusuf E, Visser AW, Kroon HM, van Osch GJVM, Zuurmond A-M, Stojanovic-Susulic V, Bloem JL, Nelissen RGHH, Huizinga TWJ, Kloppenburg M. Different patterns of synovitis as seen on CE-MRI in patients with knee osteoarthritis. Osteoarthritis Cartilage 2013, 21(suppl):S16.
22. Loeuille D, Rat AC, Goebel JC, Champigneulle J, Blum A, Netter P, Gillet P, Chary-Valckenaere I. Magnetic resonance imaging in osteoarthritis: which method best reflects synovial membrane inflammation? Correlations with clinical, macroscopic and microscopic features. Osteoarthritis Cartilage 2009, 17:1186-1192. 10.1016/j.joca.2009.03.006, 19332177.
23. Crema MD, Felson DT, Roemer FW, Niu J, Marra MD, Zhang Y, Lynch JA, El-Khoury GY, Lewis CE, Guermazi A. Peripatellar synovitis: comparison between non-contrast-enhanced and contrast-enhanced MRI and association with pain. The MOST study. Osteoarthritis Cartilage 2013, 21:413-418.
24. Roemer FW, Guermazi A, Felson DT, Niu J, Nevitt MC, Crema MD, Lynch JA, Lewis CE, Torner J, Zhang Y. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis 2011, 70:1804-1809. 10.1136/ard.2011.150243, 3496084, 21791448.
25. Vahlensieck M, Linneborn G, Schild H, Schmidt HM. Hoffa's recess: incidence, morphology and differential diagnosis of the globular-shaped cleft in the infrapatellar fat pad of the knee on MRI and cadaver dissections. Eur Radiol 2002, 12:90-93. 10.1007/s003300100982, 11868081.
26. Chuckpaiwong B, Charles HC, Kraus VB, Guilak F, Nunley JA. Age-associated increases in the size of the infrapatellar fat pad in knee osteoarthritis as measured by 3 T MRI. J Orthop Res 2010, 28:1149-1154. 10.1002/jor.21125, 3625521, 20225314.
27. Ioan-Facsinay A, Kwekkeboom JC, Westhoff S, Giera M, Rombouts Y, van Harmelen V, Huizinga TW, Deelder A, Kloppenburg M, Toes RE. Adipocyte-derived lipids modulate CD4(+) T-cell function. Eur J Immunol 2013, 43:1578-1587. 10.1002/eji.201243096, 23504601.
28. Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013, 339:172-177. 10.1126/science.1230721, 23307735.
29. Kim CS, Lee SC, Kim YM, Kim BS, Choi HS, Kwon BS, Kawada T, Yu R. Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice. Obesity (Silver Spring) 2008, 16:1261-1269.
30. Ushiyama T, Chano T, Inoue K, Matsusue Y. Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids. Ann Rheum Dis 2003, 62:108-112. 10.1136/ard.62.2.108, 1754438, 12525378.
31. Distel E, Cadoudal T, Durant S, Poignard A, Chevalier X, Benelli C. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum 2009, 60:3374-3377. 10.1002/art.24881, 19877065.
32. Klein-Wieringa IR, Kloppenburg M, Bastiaansen-Jenniskens YM, Yusuf E, Kwekkeboom JC, El-Bannoudi H, Nelissen RG, Zuurmond A, Stojanovic-Susulic V, Van Osch GJ, Toes RE, Ioan-Facsinay A. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann Rheum Dis 2011, 70:851-857. 10.1136/ard.2010.140046, 21242232.
33. Presle N, Pottie P, Dumond H, Guillaume C, Lapicque F, Pallu S, Mainard D, Netter P, Terlain B. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage 2006, 14:690-695. 10.1016/j.joca.2006.01.009, 16527497.
34. Chen WP, Bao JP, Feng J, Hu PF, Shi ZL, Wu LD. Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis. Clin Chem Lab Med 2010, 48:1141-1145.
35. Gandhi R, Takahashi M, Virtanen C, Syed K, Davey JR, Mahomed NN. Microarray analysis of the infrapatellar fat pad in knee osteoarthritis: relationship with joint inflammation. J Rheumatol 2011, 38:1966-1972. 10.3899/jrheum.101302, 21765106.
36. Shaikh SR, Jolly CA, Chapkin RS. n-3 Polyunsaturated fatty acids exert immunomodulatory effects on lymphocytes by targeting plasma membrane molecular organization. Mol Aspects Med 2012, 33:46-54. 10.1016/j.mam.2011.10.002, 3246093, 22020145.
37. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011, 12:408-415. 10.1038/ni.2022, 21478880.
38. Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008, 47:147-155. 10.1016/j.plipres.2007.12.004, 18198131.
39. Cascio G, Schiera G, Di Liegro I. Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases. Curr Diabetes Rev 2012, 8:2-17. 10.2174/157339912798829241, 22414056.
40. Serhan CN. The resolution of inflammation: the devil in the flask and in the details. FASEB J 2011, 25:1441-1448. 10.1096/fj.11-0502ufm, 3228345, 21532053.
41. Klein-Wieringa IR, Andersen SN, Kwekkeboom JC, Giera M, de Lange-Brokaar BJ, van Osch GJ, Zuurmond AM, Stojanovic-Susulic V, Nelissen RG, Pijl H, Huizinga TW, Kloppenburg M, Toes RE, Ioan-Facsinay A. Adipocytes modulate the phenotype of human macrophages through secreted lipids. J Immunol 2013, 191:1356-1363. 10.4049/jimmunol.1203074, 23817431.
42. Gierman LM, Wopereis S, van El B, Verheij ER, der Vat BJ W-V, Bastiaansen-Jenniskens YM, van Osch GJ, Kloppenburg M, Stojanovic-Susulic V, Huizinga TW, Zuurmond AM. Metabolic profiling reveals differences in concentrations of oxylipins and fatty acids secreted by the infrapatellar fat pad of end-stage osteoarthritis and normal donors. Arthritis Rheum 2013, 65:2606-2614.
43. Caspar-Bauguil S, Cousin B, Galinier A, Segafredo C, Nibbelink M, André M, Casteilla L, Pénicaud L. Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 2005, 579:3487-3492. 10.1016/j.febslet.2005.05.031, 15953605.
44. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab 2013, 17:851-859. 10.1016/j.cmet.2013.05.008, 23747244.
45. Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Györi G, Zlabinger GJ, Stulnig TM. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 2007, 31:1420-1428.
46. Curat CA, Miranville A, Sengenès C, Diehl M, Tonus C, Busse R, Bouloumié A. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285-1292. 10.2337/diabetes.53.5.1285, 15111498.
47. Duffaut C, Zakaroff-Girard A, Bourlier V, Decaunes P, Maumus M, Chiotasso P, Sengenès C, Lafontan M, Galitzky J, Bouloumié A. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol 2009, 29:1608-1614. 10.1161/ATVBAHA.109.192583, 19644053.
48. Bastiaansen-Jenniskens YM, Clockaerts S, Feijt C, Zuurmond AM, Stojanovic-Susulic V, Bridts C, de Clerck L, DeGroot J, Verhaar JA, Kloppenburg M, van Osch GJ. Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage. Ann Rheum Dis 2012, 71:288-294. 10.1136/ard.2011.153858, 21998115.
49. Chanda D, Kumar S, Ponnazhagan S. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J Cell Biochem 2010, 111:249-257. 10.1002/jcb.22701, 2946500, 20506559.
50. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, Thomas K, Austin T, Edwards C, Cuzzourt J, Duenzl M, Lucas PA, Black AC. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001, 264:51-62. 10.1002/ar.1128, 11505371.
51. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 2012, 21:2724-2752. 10.1089/scd.2011.0722, 22468918.
52. Wickham MQ, Erickson GR, Gimble JM, Vail TP, Guilak F. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res 2003, 412:196-212.
53. Dragoo JL, Samimi B, Zhu M, Hame SL, Thomas BJ, Lieberman JR, Hedrick MH, Benhaim P. Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 2003, 85:740-747.
54. Alegre-Aguaron E, Desportes P, Garcia-Alvarez F, Castiella T, Larrad L, Martinez-Lorenzo MJ. Differences in surface marker expression and chondrogenic potential among various tissue-derived mesenchymal cells from elderly patients with osteoarthritis. Cells Tissues Organs 2012, 196:231-240.
55. English A, Jones EA, Corscadden D, Henshaw K, Chapman T, Emery P, McGonagle D. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology (Oxford) 2007, 46:1676-1683.
56. Khan WS, Adesida AB, Hardingham TE. Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther 2007, 9:R55. 10.1186/ar2211, 2206341, 17537234.
57. Hui W, Litherland GJ, Elias MS, Kitson GI, Cawston TE, Rowan AD, Young DA. Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases. Ann Rheum Dis 2012, 71:455-462. 10.1136/annrheumdis-2011-200372, 22072016.
58. Bastiaansen-Jenniskens YM, Wei W, Feijt C, Waarsing JH, Verhaar JA, Zuurmond AM, Hanemaaijer R, Stoop R, van Osch GJ. Infrapatellar fat pad of OA patients stimulates fibrotic processes in cultured synoviocytes; a possible role for prostaglandin F. Arthritis Rheum 2013, 65:2070-2080. 10.1002/art.37996, 23666869.
59. Clockaerts S, Bastiaansen-Jenniskens YM, Feijt C, De Clerck L, Verhaar JA, Zuurmond AM, Stojanovic-Susulic V, Somville J, Kloppenburg M, van Osch GJ. Cytokine production by infrapatellar fat pad can be stimulated by interleukin 1beta and inhibited by peroxisome proliferator activated receptor alpha agonist. Ann Rheum Dis 2012, 71:1012-1018. 10.1136/annrheumdis-2011-200688, 22307941.
60. Manferdini C, Maumus M, Gabusi E, Piacentini A, Filardo G, Peyrafitte JA, Jorgensen C, Bourin P, Fleury-Cappellesso S, Facchini A, Noël D, Lisignoli G. Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Arthritis Rheum 2013, 65:1271-1281. 10.1002/art.37908, 23613363.
61. Blaber SP, Webster RA, Hill CJ, Breen EJ, Kuah D, Vesey G, Herbert BR. Analysis of in vitro secretion profiles from adipose-derived cell populations. J Transl Med 2012, 10:172. 10.1186/1479-5876-10-172, 3479070, 22913454.
62. de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, Zuurmond AM, Schoones J, Toes RE, Huizinga TW, Kloppenburg M. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage 2012, 20:1484-1499. 10.1016/j.joca.2012.08.027, 22960092.
63. Cooper AM, Khader SA. IL-12p40: an inherently agonistic cytokine. Trends Immunol 2007, 28:33-38. 10.1016/j.it.2006.11.002, 17126601.
64. Huebner JL, Kraus VB. Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. Osteoarthritis Cartilage 2006, 14:923-930. 10.1016/j.joca.2006.03.007, 16679035.
65. Vernal R, Velasquez E, Gamonal J, Garcia-Sanz JA, Silva A, Sanz M. Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint. Arch Oral Biol 2008, 53:910-915. 10.1016/j.archoralbio.2008.04.004, 18508030.
66. Van Beeck A, Clockaerts S, Somville J, Van Heeswijk JH, Van Glabbeek F, Bos PK, Reijman M. Does infrapatellar fat pad resection in total knee arthroplasty impair clinical outcome? A systematic review. Knee 2013, 20:226-231. 10.1016/j.knee.2013.01.005, 23566735.